Agreement signedPublished 13 Apr 2023

Meilleur Technologies, Inc. /
Navidea Biopharmaceuticals, Inc.

Meilleur Technologies to purchase Navidea Alzheimer’s business assets

Terms
Not stated
Stage
Agreement signed
Buy side: Meilleur Technologies, Inc.
Buy sideMeilleur Technologies, Inc.
Target: Navidea Biopharmaceuticals, Inc.
TargetNavidea Biopharmaceuticals, Inc.
Source · 13 Apr 2023
Buy side: Meilleur Technologies, Inc.
Buy sideMeilleur Technologies, Inc.
Target: Navidea Biopharmaceuticals, Inc.
TargetNavidea Biopharmaceuticals, Inc.
01 / BuyerMeilleur Technologies, Inc.
02 / TargetNavidea Biopharmaceuticals, Inc.
01

What happened

Meilleur Technologies, Inc. agreed to acquire certain assets and assume certain liabilities of Navidea Biopharmaceuticals, Inc. relating to the development and commercialization of PET biomarkers for Alzheimer’s Disease.

The purchase price is $750, 000, with additional contingent and milestone payments tied to potential licensing events, regulatory milestones and product sales.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Meilleur Technologies to purchase Navidea Alzheimer’s business assets

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.